Alder Biopharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Alder Biopharmaceuticals Ownership

Who owns Alder Biopharmaceuticals?

Alder Biopharmaceuticals is owned by H. Lundbeck A/S. It was acquired on September 16, 2019.

Alder Biopharmaceuticals Business Overview

Where is Alder Biopharmaceuticals headquartered?

Alder Biopharmaceuticals is headquartered in Bothell, Washington.

What is Alder Biopharmaceuticals’ revenue?

Alder Biopharmaceuticals disclosed revenue of 2M USD for 2017 and 55M USD for 2014.

How many employees does Alder Biopharmaceuticals have?

Alder Biopharmaceuticals has 202 employees.

What sector is Alder Biopharmaceuticals in?

Alder Biopharmaceuticals is a life science company.

When was Alder Biopharmaceuticals founded?

Alder Biopharmaceuticals was founded in 2002.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Alder Biopharmaceuticals, Inc.

11804 North Creek Parkway South,
Bothell, Washington 98011
United States,
(425) 205-2900
www.alderbio.com

Alder Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel antibodies that originate from its proprietary platform for the production of antibodies in picchia. Alder Biopharmaceuticals was formed in 2002 and is based in Bothell, Washington.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.